AFC-HD AMS Life Science Co Ltd
TSE:2927
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AFC-HD AMS Life Science Co Ltd
Revenue
AFC-HD AMS Life Science Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AFC-HD AMS Life Science Co Ltd
TSE:2927
|
Revenue
¥32.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Revenue
¥970B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Revenue
¥335.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Kao Corp
TSE:4452
|
Revenue
¥1.7T
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
F
|
Fancl Corp
TSE:4921
|
Revenue
¥109B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Revenue
¥165.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
AFC-HD AMS Life Science Co Ltd
Glance View
AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. The company is headquartered in Shizuoka-Shi, Shizuoka-Ken and currently employs 793 full-time employees. The company went IPO on 2005-03-03. The firm is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The firm operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The firm is also engaged in the management of restaurants through subsidiary.
See Also
What is AFC-HD AMS Life Science Co Ltd's Revenue?
Revenue
32.9B
JPY
Based on the financial report for Feb 28, 2026, AFC-HD AMS Life Science Co Ltd's Revenue amounts to 32.9B JPY.
What is AFC-HD AMS Life Science Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for AFC-HD AMS Life Science Co Ltd have been 11% over the past three years , 14% over the past five years , and 8% over the past ten years .
